Innovation, it’s in our DNA


Allegra Orthopaedics specialises in bringing innovation to market. Allegra’s principal product, the Active Total Knee, is such an example and has significantly improved the quality of life for many people globally.

The company is the global licensee to a composite biocompatible ceramic material, known as Sr-HT-Gahnite, from The University of Sydney. The Sr-HT-Gahnite is currently under development and preliminary studies indicate good bioactivity and in-growth of bone into the synthetic scaffold prepared from the ceramic material.

The company continues to build upon its extensive portfolio of patents. Allegra has built strong relationships with medical device companies and research organisations, such as The University of Sydney, University of Wollongong and Queensland University of Technology, as well as Surgeon inventors/innovators. These collaborations have resulted in commercialisation of new medical devices in the market.
To find out more, contact us here.


Meet Dr Roger Brighton, Surgeon Advisor

Read More

Our Most Current Project

The Sr-HT-Gahnite is currently under development and preliminary studies indicate good bioactivity.

Read More

What is in the Pipeline?

We embrace innovation by fostering research and manufacturing projects. This is why Allegra enjoys a collaborative relationship with Bone Ligament Tendon (BLT).

Read More

Are you an Inventor?

If you are interested in partnering with Allegra, the company can provide support with a complete range of services to take your ideas from conception, into production and market release.

Read More

Link Megasystem-C


Modular tumour and revision system

The high modularity of the MEGASYSTEM-C® allows partial bone replacements both in the proximal and distal femur in small increments. The system also allows for a total femoral replacement.

Compatible with successful revision systems (MP® Reconstruction Prosthesis and Endo-Model® SL Knee Prosthesis System).

Intraoperative flexibility for the Surgeon with various combination options.

Contact Us

Keep up to date!

Receive newsletter updates weekly.

Sign Up